← Leaderboards
Steven P Linke
Prediction Sciences, Llc
$2,199,664
Attributed
$2,199,664
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $882.5K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,199,664 · 3
By mechanism
R44$2,099,664 · 2
R43$100,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Prediction Sciences, Llc
Same institution · by research overlap
- Albert K Man$1,810,626
- Troy M Bremer$1,015,748
Others in their field
Top investigators on “Recurrence”
- Philip J Disaia · University Of California Irvine$95,481,777
- David Heimbrook · Leidos Biomedical Research, Inc.$87,033,539
- Wafaa M. El-Sadr · Columbia University Health Sciences$84,793,830
- Myron S Cohen · Family Health International$84,793,830
- Lawrence Corey · Fred Hutchinson Cancer Center$59,594,035
- Dan H. Barouch · Fred Hutchinson Cancer Center$59,594,035
Research focus
RecurrenceTumor TissueImmunohistochemistryQuality Of LifeStaining MethodTumorEnsureGuidelinesPerformancePublishingSamplingStagingStainsTissue MicroarrayBaseComputer SoftwareAdjuvantFormalinMalignant NeoplasmsParaffin EmbeddingPrognosticProteinsRunningValidation
Grant awards (5)
Multi-marker prognostic profile to predict invasive progression in DCIS patients$653,297
R44 · FY2014 · CA · contact PI
Multi-marker prognostic profile to predict invasive progression in DCIS patients$273,920
R44 · FY2012 · CA · contact PI
GeneRx - colorectal cancer recurrence prediction$289,916
R44 · FY2008 · CA · contact PI
GeneRx - colorectal cancer recurrence prediction$882,531
R44 · FY2007 · CA · contact PI
GeneRx - colorectal cancer recurrence prediction$100,000
R43 · FY2005 · CA